Approval · Notice of Compliance 15401 · 2014
LATUDA: Notice of Compliance 15401
Issued March 13, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15401
- Date
- March 13, 2014
- Company
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LATUDA | 02422050 | Cancelled Post Market |
Medicinal ingredients
- LURASIDONE HYDROCHLORIDE 20 MG per TAB